01346nam 2200361Ia 450 991069905080332120090821135927.0(CKB)5470000002399378(OCoLC)432326260(EXLCZ)99547000000239937820090821d2002 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierGuidance for industry[electronic resource] information program on clinical trials for serious or life-threatening diseases and conditionsRockville, MD :U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,[2002]1 online resource (9 pages) digital, PDF file"Center for Biologics Evaluation and Research (CBER).""Procedural.""March 2002."Guidance for industry Clinical trialsGovernment policyUnited StatesClinical trialsGovernment policyCenter for Drug Evaluation and Research (U.S.)Center for Biologics Evaluation and Research (U.S.)GPOGPOBOOK9910699050803321Guidance for industry3434577UNINA01307cam2 22003011 450 SOBE0002192920260108134315.020120126d1991 |||||ita|0103 baitaIT<<Il >>Canone di Avicenna fra Europa e Oriente nel primo Cinquecento : l'Interpretatio Arabicorum nominum di Andrea Alpago / a cura di Giorgio VercellinTorinoUTET1991142 p.ill.25 cm001SOBE000831282000 Strenna UtetAlpago, AndreaSOBA00002565070774538Vercellin, GiorgioAF00011175070AvicennaAF00005997070ITUNISOB20260108RICAUNISOBUNISOB000|Coll|54|K75218UNISOBFondo|Calì184496SOBE00021929M 102 Monografia moderna SBNM000|Coll|54|K000028SI75218acquistoNvittoriniUNISOBUNISOB20120126161456.020120326092803.0vittoriniFondo|Calì002075SI18449620260623CaliDonoNrovitoUNISOBUNISOB20260108134143.020260108134315.0rovitoCanone di Avicenna fra Europa e Oriente nel primo Cinquecento : l'Interpretatio Arabicorum nominum di Andrea Alpago1719309UNISOB